Title: RNAi Expression Constructs
Patent Number: 7,803,611
Filed: Feb. 3, 2006
Lead Inventor: Petrus Roelvink, Benitec
The invention, the patent's abstract states, "provides compositions and methods suitable for expressing 1-x RNAi agents against a gene or genes in cells, tissues, or organs of interest in vitro and in vivo so as to treat diseases or disorders.